Cepheid Wins FDA Approval for Xpress Flu, Flu/RSV Tests

Feb 15, 2017

NEW YORK (GenomeWeb) – Cepheid's Xpert Xpress Flu and Xpert Xpress Flu/RSV tests have received clearance from the US Food and Drug Administration, the firm announced today.

The tests are the first in the firm's planned line of Xpress branded tests — faster versions of the firm's Xpert test cartridges enabling test times of 30 minutes or less.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Main menu

Cepheid Wins FDA Approval for Xpress Flu, Flu/RSV Tests

To read the full story....

Breaking News

Myriad Genetics Fiscal Q4 Revenues Up 1 Percent

ACLA Expresses Concern Over FDA's Proposal for Regulating In Vitro Diagnostic Tests

FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer

DoD Awards Fox Chase Researcher $673K to Develop Lung Cancer Test

FDA Clears Techlab's H. Pylori Tests

Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay

Featured White Papers

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

What's Popular?

PGx Experts Encourage Greater Standardization of Tests to Improve Adoption, Patient Care

ACLA Expresses Concern Over FDA's Proposal for Regulating In Vitro Diagnostic Tests

MBio Diagnostics Raises Additional $6M in Series B Funding Round

Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay

Qiagen Names TSG Exclusive Commercial Partner in Africa

Sponsorships